- Home
- DRRX vs IRIX Comparison
DRRX vs IRIX Comparison
Compare DRRX & IRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRRX
- IRIX
- Stock Information
- Founded
- DRRX 1998
- IRIX 1989
- Country
- DRRX United States
- IRIX United States
- Employees
- DRRX N/A
- IRIX N/A
- Industry
- DRRX Biotechnology: Pharmaceutical Preparations
- IRIX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- DRRX Health Care
- IRIX Health Care
- Exchange
- DRRX Nasdaq
- IRIX Nasdaq
- Market Cap
- DRRX 26.4M
- IRIX 28.6M
- IPO Year
- DRRX 2000
- IRIX 1996
- Fundamental
- Price
- DRRX $0.85
- IRIX $1.66
- Analyst Decision
- DRRX Buy
- IRIX Hold
- Analyst Count
- DRRX 2
- IRIX 1
- Target Price
- DRRX $5.00
- IRIX $2.00
- AVG Volume (30 Days)
- DRRX 124.4K
- IRIX 52.5K
- Earning Date
- DRRX 11-13-2024
- IRIX 11-12-2024
- Dividend Yield
- DRRX N/A
- IRIX N/A
- EPS Growth
- DRRX N/A
- IRIX N/A
- EPS
- DRRX N/A
- IRIX N/A
- Revenue
- DRRX $8,594,000.00
- IRIX $48,431,000.00
- Revenue This Year
- DRRX $54.32
- IRIX N/A
- Revenue Next Year
- DRRX N/A
- IRIX $5.44
- P/E Ratio
- DRRX N/A
- IRIX N/A
- Revenue Growth
- DRRX N/A
- IRIX N/A
- 52 Week Low
- DRRX $0.68
- IRIX $1.27
- 52 Week High
- DRRX $1.88
- IRIX $3.65
- Technical
- Relative Strength Index (RSI)
- DRRX 47.88
- IRIX 47.67
- Support Level
- DRRX $0.79
- IRIX $1.60
- Resistance Level
- DRRX $0.86
- IRIX $1.67
- Average True Range (ATR)
- DRRX 0.08
- IRIX 0.11
- MACD
- DRRX 0.01
- IRIX -0.01
- Stochastic Oscillator
- DRRX 51.69
- IRIX 25.81
About DRRX DURECT Corporation
Durect Corp is a biopharmaceutical company. It is engaged in the research, development, and manufacturing of pharmaceutical products. The company develops pharmaceutical products based on two categories which include new chemical entities and proprietary pharmaceutical programs. The company's pipeline products consist of DUR-928, POSIMIR, and others. Geographically, the company operates in the United States, Europe, Japan, and other countries, of which key revenue is derived from the Europe .
About IRIX IRIDEX Corporation
IRIDEX Corp is involved in the business of developing, manufacturing, and marketing laser-based medical systems, delivery devices, and consumable instrumentation for ophthalmology. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.